2022
-
2021
-
2020
-
2019
-
2018
-
2017
Events
2022
2021
2020
2019
2018
2017
|
|
|
|
|||||||||
| |
||||||||||||
|
|
|
|
|||||||||
| |
||||||||||||
|
For more information about past events, please contact events@eaaci.org
 |
 |
 |
 |
 |
 |
 |
 |
Please find all abstract supplements from the EAACI Annual Congresses in the special issue of the journal Allergy here.
2022
-
2019
-
2018
-
2017
Master Class on Translational Immunology in Allergic Diseases
21 – 22 October 2016
Zurich, Switzerland
Organisers: EAACI Immunology Section and the Biologicals Interest Group
In 2016, for the first time, the Immunology Section and the Biologicals Interest Group of EAACI will organise a Master Class on Translational Immunology in Allergic Diseases. State of the art training on novel therapies and current unmet needs in allergic disorders will be addressed. Participants will receive the knowledge and training required to effectively use these immunological tools in the clinic.
Programme
The Master Class will be held over two days and will include plenary style lectures, coupled with interactive case discussion sessions.
During the first day, leading experts in the field will provide comprehensive updates on how to identify phenotypes and immunological endotypes in patients suffering from asthma, allergic rhinitis, atopic dermatitis, urticaria, food allergy, eosinophilic esophagitis and those patients undergoing immunotherapy. The basic immunological mechanisms underpinning these clinical phenotypes and endotypes will also be discussed.
During the second day, there will be detailed clinical presentations on the use of anti-IgE, anti-IL-5, anti-IL-4 and anti-IL-13 in the clinic. Specifically, participants will learn how and when to use these biologics, how to prevent, recognise and manage side-effects and how to treat difficult patients. Interactive sessions involving case presentations by faculty and participants will ensure that the new knowledge can be applied in a real world setting. Finally, novel immune targets and microbiome targets currently in development and clinical trials for allergy and asthma patients will be discussed.
Click below to access the scientific programme:
Target Audience
Whereas EAACI’s Allergy Schools are tailored for more junior attendees, the Master Class requires a higher level of professional experience and offers an excellent platform for exchange of knowledge. However, age is not a criterion for exclusion.
The target audience is specialised clinicians working in the fields of allergy and asthma who want to know more about the link between clinical presentation and treatment options with biologics based on endotyping.
CME Accreditation
This Masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS) in cooperation with the European Board of Accreditation in Allergy and Clinical Immunology (EBAACI) to provide the following CME activity for medical specialists. The Congress has been designated for 9 hours of European external CME credits (ECMECs).*
SSAI accreditation
The Swiss Society for Allergology and Immunology (SSAI) has evaluated this event. The programme of the event has been accepted as valid for continuous medical education and is accredited with 12 credits SSAI.
Submission of case reports
This Master Class will have an interactive session in which difficult cases submitted by attendees will be discussed. Please contact EAACI HQ at education@eaaci.org for further information if you would like to discuss a case.
Master Class Venue
The Master Class will take place in the Sheraton Zurich Hotel.
Sheraton Zurich Hotel
Pfingstweidstrasse 100
8005 Zurich
Switzerland
Tel: +41 44 285 40 00
info.sheratonzurich@sheraton.com
www.sheratonzurichhotel.com
Registration
The EAACI Master Class on Translational Immunology in Allergic Diseases has reached the maximum capacity and registration is now closed.
Registration Fees
Early bird registration fees until 19 August 2016:
EAACI Member* / EAACI Junior Member EUR 500.00
Non-Member EUR 800.00
Registration fee after 19 August 2016:
EAACI Member* / EAACI Junior Member EUR 600.00
Non-Member EUR 900.00
*Only EAACI Members who have paid the full amount of their membership fee are entitled to this reduced fee. Please make sure to pay the EAACI membership before you register for this Master Class.
Registration for the Master Class includes:
- Course material (programme book, speaker handouts)
- Coffee breaks
- Welcome reception on Friday
- Lunch on Saturday
The registration fee does not include travel costs and accommodation.
A promotional code for a recommended hotel will be available shortly and participants are requested to handle their own hotel booking and travel arrangements.
We are looking forward to seeing you in Zurich.
| Liam O’Mahony Chair Immunology Section |
Onur Boyman Chair Biologicals Interest Group |
Peter Schmid-Grendelmeier Vice President Education and Specialty |
*EACCME credits are recognised in Europe and by the American Medical Association (AMA) towards the Physician’s Recognition Award (PRA). In order to convert EACCME credit to AMA PRA category 1 credit, please contact the AMA office for more information. Furthermore, live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
Personalised Treatments of Chronic Inflammatory Upper and Lower Airways Disease:
Biologicals, Immunomodulators and Other Targeted Therapeutics
13 - 14 April 2018 Prague, The Czech Republic
Organised by:
Asthma Section, ENT Section, Basic & Clinical Immunology Section
Educational Aims:
The increasing insight into the genetic, innate and adaptive mechanisms and their interaction with the environmental factors in asthma and allergic disease gives rise to targeted treatments. This master class will review and highlight important aspects and novel insights into the basic mechanisms and how they translate into the clinical presentation of (non) allergic asthma and rhinitis. In addition, novel targeted therapeutic options, including biologicals, anti-mediator drugs and immunomodulators, will be addressed while experience with these agents in clinical practice will be discussed in plenary sessions and workshops.
Expected Learning Outcomes:
We anticipate that the set up and the topics in this master class will broaden insights into the underlying mechanisms and the links to targeted therapeutic options for (non) allergic asthma and upper airway disease. The international exchange of clinical experience with these novel agents and discussions on potential future applications should create a platform to define unmet (research) needs.
So, attending this master class the participants will receive updates and gain insight into:
- innate and adaptive basic mechanisms in asthma and rhinitis
- the role of microbioma within upper and lower airways
- the role of biomarkers, phenotypes, and endotypes in precision medicine of asthma and rhinitis available biologicals and their effectiveness in the treatment of asthma and rhinitis (which patients benefit from what biologicals?)
- the role of allergen immunotherapy in the treatment of allergic asthma and rhinitis
- potential novel therapeutic targets in asthma and rhinitis
- how to apply targeted therapy in asthma and rhinitis through case reports and interactive sessions with experts
Target Audience:
Whereas EAACI’s allergy schools are tailored for more junior attendees, master classes require a higher level of professional experience and offer an excellent platform for the exchange of knowledge. However, age is not a criterion for exclusion.
This master class is intended for clinicians, researchers and lab specialists who want to learn more about Treatments of Chronic Inflammatory Upper and Lower Airways Disease, focusing on Asthma and Rhinitis.
CME Accreditation:
The EAACI Master Class on Biologicals Personalised Treatments of Chronic Inflammatory Upper and Lower Airways Disease: Biologicals, Immunomodulators and Other Targeted Therapeutics, Prague, Czech Republic, 13/04/2018-14/04/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
For more information regarding CME accreditation, please click here.
Submission of Case Reports:
This master class will include interactive case reports and plenary discussion sessions in which case reports submitted by attendees will be discussed. Case reports can now be submitted by email to education@eaaci.org
Furthermore, the cases can be presented with or without slides and will be discussed with faculty and attendees.
Programme:
The master class will be held over two days and will include lectures, workshops, practical discussions, and case presentations.
Topics covered:
- Innate and adaptive Immunity in Rhinitis and Asthma
- The Role of Microbiome in Upper & Lower Airways and the Effect of Treatment
- Mechanisms driving Corticosteroid Insensitivity
- Endotype-driven Treatment – a Step towards Precision Medicine in Asthma
- Anti-mediator Approaches for Asthma
- Role of Biologicals in Asthma Comorbidities
- New Therapeutic Targets: where do we stand? (Includes anti-IL25/anti-IL-33/anti-TSLP; PI3K inhibitors/antibiotics)
- Which phenotypes benefit from SCIT; which from SLIT?
- Which phenotypes benefit from anti-IgE and which type of anti-IgE treatment?
- Which phenotypes benefit from anti-IL-5, anti-IL-4 and/or anti-IL-13)-directed approaches?
- Uncontrolled allergic and non-allergic Rhinitis (Includes diagnosis/ Biomarkers; dysfunctional barrier; treatment options e.g. IT, Biologicals, other)
- Recalcitrant Chronic Rhinosinusitis (Includes diagnosis/Biomarkers; IT, Biologicals, other)
- Endotype-driven Treatment of Chronic Rhinosinusitis with Nasal Polyps (Includes Diagnosis/Biomarkers, Biologicals, Antibiotics, other)
Venue
The master class will take place at the Lindner Hotel Prague Castle at one of the most beautiful locations in Prague.
Address:
Lindner Hotel Prague Castle
Strahovska 128
118 00 Prague
Czech Republic
Website
If you wish to accommodate at the Lindner Hotel Prague Castle for a price of EUR 125 (price per room including breakfast, single occupancy, per night) please fill this form, and send it directly to the hotel at the address provided in the form.
Please note that EAACI cannot be held responsible for any accommodation request/refund.
Registration:
The EAACI Master Class Master Class on Biologicals has reached the maximum capacity and registration is now closed.
Registration Fees:
Early bird registration fees until 2 February 2018:
EAACI Member* / EAACI Junior Member EUR 500.00
Non-Member EUR 800.00
Registration fee after 2 February 2018:
EAACI Member* / EAACI Junior Member EUR 600.00
Non-Member EUR 900.00
*Only EAACI Members who have paid the full amount of their membership fee are entitled to this reduced fee. Please make sure to pay the EAACI membership before you register for this Master Class.
Registration for the Master Class includes:
- Coffee breaks (morning and afternoon)
- Lunch on Friday and Saturday
- Welcome dinner on Friday
The registration fee does not include travel costs and accommodation.
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
AIM Group International - AIM Education S.r.l.
Valentina Disabato/Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan, Italy
Tel. +39 02 56601.1
FAX +39 02-70048585
e-mail: aifa@aimgroup.eu
We are looking forward to seeing you in Prague.
Organising Committee
Zuzana Diamant
Local Organising Chair
Oscar Palomares Gracia
Local Organising Secretary
Philippe Gevaert
ENT Section Chair
Martina Vasakova
Asthma Section Board Member
For more information, please contact:
EAACI Headquarters
Hagenholzstrasse 111
3rd Floor
8050 Zurich
Switzerland
Tel: +41 44 205 55 33
Scientific aspects: education@eaaci.org
Logistical aspects: events@eaaci.org
Potential Conflict of Interest Declaration
The European Academy of Allergy and Clinical Immunology (EAACI) takes pride in offering scientific educational events of the highest standard. In accordance with UEMS criteria EAACI dutifully request all committee and faculty members to declare any interests they may have which could influence, or might be perceived to influence their judgement or behaviour.
Please click on the following links to view the respective Conflict of Interest forms.
- Committee
- Faculty
This section contains information that is promotional in nature, distinct from the scientific/educational content.
This event is organized by EAACI with funding support from Novartis Pharma AG and ALK.
EAACI Master Class on Occupational Allergy
Biomarkers and Personalized medicine in Occupational Respiratory Allergic Diseases
Madrid, Spain, 29 – 30 September 2017
Organisers: IG Environmental and Occupational AllergyEducational aims
The rapid increase and application of molecular techniques to the field of asthma and allergic airway diseases has resulted in the emergence of new biomarkers for disease presence, susceptibility, and even differential response to treatment and allergen avoidance. These advances are also affecting occupational airways diseases, and the new tools and insights being developed are laying the foundation of precision or personalised medicine in the occupational respiratory field. The main goal of this master class will be to review the importance and role of different known and potential biomarkers useful to define the pathophysiological and clinical profiles of patients affected by occupational lung disease, particularly occupational asthma. In addition, the burden and the clinical aspects, phenotypes and pathophysiology of occupational allergic respiratory diseases will be addressed.
Expected outcome and potential impact in practice after the master class
By stimulating transnational exchange of experience and knowledge related to issue of application of molecular techniques to the field of occupational asthma and allergic airway diseases, the meeting will contribute to increase awareness of modern solutions in everyday practice and scientific research. All participants will have an opportunity to share their arguments and develop common innovative solutions aiming at increasing capacities of diagnostics of occupational allergy and further development of research practices.
Programme
The master class will be held over two days and will include lectures, workshops, practical discussions, a visit to challenge chambers and case presentations.
Topics covered:
- International trends in the prevalence and incidence of occupational allergic respiratory diseases (work-related asthma, hypersensitivity pneumonitis)
- New insights on the pathogenesis of allergic occupational asthma and irritant-induced asthma
- Dose-response relationships with occupational allergens
- Clinical investigations in patients with suspected occupational respiratory disease
- Molecular diagnostics in the occupational setting
- Standardized methods for nasal and bronchial provocation tests with occupational agents
- Phenotypes of work-related asthma
- Usefulness of biomarkers (sputum, serum, urine)
- Occupational asthma in farming and in the food industry
- Follow-up and outcome of patients with work-related asthma
- Nasal and bronchial provocation tests with occupational allergens
- Assessment of airway inflammation in the occupational setting
Click below to access the scientific programme:
Target Audience
Whereas EAACI’s allergy schools are tailored for more junior attendees, master classes requires a higher level of professional experience and offers an excellent platform for the exchange of knowledge. However, age is not a criterion for exclusion.
This master class is intended for clinicians, researchers and lab specialists who want to learn more about Occupational Allergy.
CME Accreditation
The EAACI Master Class on Occupational Allergy, Biomarkers and Personalized medicine in Occupational Respiratory Allergic Diseases, Madrid, Spain, 29/09/2017-30/09/2017 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
EACCME® credits
Each participant can only receive the number of credits he/she is entitled to according to his/her actual participation at the event once he/she has completed the feedback form. Cf. criteria 9 and 23 of UEMS 2016.20. In order to help you issue individual certificates to each participants, please find below the breakdown of ECMEC®s per day:
29.09.2017 - 5,00
30.09.2017 - 6,00
The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day. Cf. Chapter X of UEMS 2016.20.
Download your CME Certificate and Certificate of Attendance
Submission of case reports
This master class will include an interactive sessions/round table in which case reports submitted by attendees will be discussed. Case reports can now be submitted by email to education@eaaci.org
Furthermore, the cases can be presented with or without slides and will be discussed with faculty and attendees.
Venue
The venue of the master class will be:
Hospital La Paz
Paseo de la Castellana, 261
28046 Madrid
Tel: +34 917 27 70 00
Website click here
Registration
Online registration will be available until the maximum capacity of 50 participants is reached.
Registration Fees
Early bird registration fees until 19 July 2017:
EAACI Member* / EAACI Junior Member EUR 500.00
Non-Member EUR 800.00
Registration fee after 19 July 2017:
EAACI Member* / EAACI Junior Member EUR 600.00
Non-Member EUR 900.00
*Only EAACI Members who have paid the full amount of their membership fee are entitled to this reduced fee. Please make sure to pay the EAACI membership before you register for this master class.
Registration for the master class includes:
- Coffee breaks
- Welcome reception on Friday
- Lunch on Saturday
The registration fee does not include travel costs and accommodation.
We are looking forward to seeing you in Madrid.
Organising Committee
Santiago Quirce
Local Organising Chair
Jolanta Walusiak-Skorupa
Local Organising Secretary
Joaquín Sastre
President Sociedad Española de Alergología e Inmunología Clínica
Potential Conflict of Interest Declaration
The European Academy of Allergy and Clinical Immunology (EAACI) takes pride in offering scientific educational events of the highest standard. In accordance with UEMS criteria EAACI dutifully request all committee and faculty members to declare any interests they may have which could influence, or might be perceived to influence their judgement or behaviour.
Please click on the following links to view the respective Conflict of Interest forms.
- Committee
- Faculty
23 - 24 March 2018, Rauischholzhausen, Germany
Organised by:
Interest Group Allergy Diagnosis & Systems Medicine
Educational Aims:
We present cutting edge molecular, cellular and social media tools for allergy diagnosis in alternating theoretical and practical sessions. Participants will have learned from experts how to apply these tools, and will have discussed them in small group seminars with faculty.
Expected Learning Outcomes:
Key aspects of allergy diagnostics will be covered in this master class, entailing both theoretical and practical considerations:
- A comprehensive overview of newly emerging biomarkers in allergy will be provided
- Scientific background, indications, advantages, and tools for Component Resolved Diagnosis (CRD) and cellular allergy testing will be presented
- Distinct clinical allergies such as food, inhalant, and insect venom allergies will be dealt with in specific talks by expert faculty
- Mobile health technologies for the diagnosis and monitoring of allergy will be presented
- Participants of the master class will learn how to integrate these components in state of the art allergy diagnosis
Target Audience:
Master classes require a higher level of professional experience and offers an excellent platform for the exchange of knowledge. However, age is not a criterion for exclusion.
The present master class targets senior members of the Academy, with an already established (at least minimal) experience and interest in clinical allergy diagnostics.
CME Accreditation:
The EAACI Master Class on Practical Allergy Diagnosis, Rauischholzhausen, Germany, 23/03/2018- 24/03/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
A CME Certificate with the specific number of acquired credits will be sent to all participants after the meeting. Please make sure you scan your badge at the entrance in front of each session room, in order to obtain the CME credits.
For more information regarding CME accreditation, please click here.
Submission of Case Reports:
This master class will include interactive sessions/round table discussions in which case reports submitted by attendees will be addressed. Case reports can now be submitted by email to education@eaaci.org
Cases can be presented with or without slides and will be discussed with faculty and attendees.
Programme:
Topics Covered:
- Component resolved diagnosis
- Basophil activation testing
- Mobile health technology for monitoring of allergy
- Emerging Biomarkers of allergy
- Frontiers of Diagnosis of major allergic disease in secondary care
Venue:
Schloss Rauischholzhausen
35085 Rauischholzhausen
Germany
Website
Telephone: +49 6424 301 100
Registration
Online registration will be available until the maximum capacity of 50 participants is reached.
Registration Fees:
Early bird registration fees until 11 January 2018:
EAACI Member* / EAACI Junior Member EUR 500.00
Non-Member EUR 800.00
Registration fee after 11 January 2018:
EAACI Member* / EAACI Junior Member EUR 600.00
Non-Member EUR 900.00
The registration fee does NOT include travel costs and accommodation.
*Only EAACI Members who have paid the full amount of their membership fee are entitled to this reduced fee. Please make sure to pay the EAACI membership before you register for this master class.
Registration for the master class includes:
- Coffee breaks
- Welcome reception on Friday
- Lunch on Saturday
Accommodation:
There is a limited number of accommodation at the meeting venue available. The price for a single room is EUR 35.60 per person per night including breakfast. If you want us to reserve a room, please send an email with the dates of arrival and departure to events@eaaci.org.
Other hotel recommendation: http://www.zumstern.de/ (10 minutes walking distance and 2 minutes by car)
We are looking forward to seeing you in Rauischholzhausen!
Organising Committee:
Chrysanthi Skevaki
Local Organising Chair
Hans Jürgen Hoffmann
Organising Secretary
Paolo Maria Matricardi
Interest Group Allergy Diagnosis & Systems Medicine Chair
For more information, please contact:
EAACI Headquarters
Hagenholzstrasse 111
3rd Floor
8050 Zurich
Switzerland
Tel: +41 44 205 55 33
Scientific aspects: education@eaaci.org
Logistical aspects: events@eaaci.org
Potential Conflict of Interest Declaration
The European Academy of Allergy and Clinical Immunology (EAACI) takes pride in offering scientific educational events of the highest standard. In accordance with UEMS criteria EAACI dutifully request all committee and faculty members to declare any interests they may have which could influence, or might be perceived to influence their judgement or behaviour.
Please click on the following links to view the respective Conflict of Interest forms.
- Committee
- Faculty
Master Class on Primary Immunodeficiencies
7 – 8 April 2017
Prague, The Czech Republic
Organisers: EAACI Primary Immunodeficiencies Interest Group
Programme
The main aim of Master Class for Primary Immunodeficiencies lies in a complex intensive course covering the many aspects of PID, mainly diagnosis and therapy. It also serves as an excellent opportunity to promote increasing awareness about primary immunodeficiencies. Furthermore the programme will go deeply into details in description of individual primary immunodeficiencies.
The Master Class will be held over two days and will include plenary style lectures, coupled with interactive case discussion sessions and practical parts.
Topics covered:
- The immune system
- PID, their diagnosis, treatment and management
- Disorders of innate immunity
- Severe combined immunodeficiency, diagnosis, newborn screening
- Hyper IgE syndroms, STATs and immundeficiencies
- Syndromes associated with immunodeficiencies
- Cell signalling defects
- Genetics, novel methods, next generation sequencing
- Bone marrow transplantation
- Thymus and immunoregulation
- Diagnostic methods in primary immunodeficiencies, flow cytometry
Click below to access the scientific programme:
Target Audience
Whereas EAACI’s Allergy Schools are tailored for more junior attendees, the Master Class requires a higher level of professional experience and offers an excellent platform for exchange of knowledge. However, age is not a criterion for exclusion.
The Master Class is intended for clinicians, researchers and lab specialists who want to learn more about primary immunodeficiencies and the link to allergic diseases.
CME Accreditation
The EAACI Master Class on Primary Immunodeficiencies has been granted 8 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).
Master Class on Primary Immunodeficiencies has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide CME Credits for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
EACCME credits are recognised in Europe and by the American Medical Association towards the Physician’s Recognition Award (PRA). In order to convert EACCME credit to AMA PRA category 1 credit, please contact the AMA office for more information. Furthermore, live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
A CME Certificate with the number of credits earned will be sent to all participants after the Master Class.
Submission of case reports
This Master Class will include two interactive sessions in which difficult cases submitted by attendees will be discussed. Case reports can now be submitted online until 15 March 2017. Case presentations can be presented with or without slides and will be discussed with faculty and attendees.
Master Class Venue
The venue of the Master Class will be:
Andel's Hotel Prague
Stroupeznickeho 21
15000 Prague, The Czech Republic
Website Click here
Tel.: +420 296 889 688.
Registration
The EAACI Master Class on Primary Immunodeficiencies has reached the maximum capacity and registration is now closed.
If you would like to be placed on the registration waiting list, please contact the registration team at events@eaaci.org.
Registration Fees
Early bird registration fees until 31 January 2017:
EAACI Member* / EAACI Junior Member EUR 500.00
Non-Member EUR 800.00
Registration fee after 31 January 2017:
EAACI Member* / EAACI Junior Member EUR 600.00
Non-Member EUR 900.00
*Only EAACI Members who have paid the full amount of their membership fee are entitled to this reduced fee. Please make sure to pay the EAACI membership before you register for this Master Class.
Registration for the Master Class includes:
- Coffee breaks
- Welcome reception on Friday
- Lunch on Saturday
The registration fee does not include travel costs and accommodation.
We are looking forward to seeing you in Prague.
| Anna Sediva Master Class Chair |
Carlo Agostini Chair Primary Immunodeficiencies Interest Group |
Peter Schmid-Grendelmeier Vice President Education and Specialty |
Endorsed by the European Society for Immunodeficiencies
For more information please contact:
EAACI Headquarters
Hagenholzstrasse 111
3rd Floor
8050 Zurich
Switzerland
Tel: +41 44 205 55 333
Scientific enquiries: education@eaaci.org
Logistical enquiries: events@eaaci.org
Call for Meeting Chairs and Venue Proposals EAACI Food Allergy and Anaphylaxis Meeting (FAAM) 2022
EAACI would like to invite its members with an open call to submit proposals for Meeting Chairs and Venues for the EAACI Food Allergy and Anaphylaxis Meeting (FAAM) 2022 which shall take place in Autumn 2022, preferably in October. Deadline for submission is 25 November 2020, 23:59 CET. Please note that for any submission the EAACI Food Allergy Interest Group Chair has to be involved. More information can be found here.Click here to submit your proposal
